<DOC>
	<DOCNO>NCT01499732</DOCNO>
	<brief_summary>Premature Endothelial Dysfunction present patient early rheumatoid arthritis .</brief_summary>
	<brief_title>Exploratory Trial Evaluate Premature Endothelial Dysfunction Early Rheumatoid Arthritis ( RA ) Compared Patients With Established RA , Normal Subjects</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<criteria>Group 1 1 . Subjects currently experience active early RA ( duration symptom ≤ 2 year ) accord 2010 ACR/EULAR criterion diagnosis RA screening . 2 . Subjects early RA must drug naïve ( prior treatment traditional diseasemodifying antirheumatic drug ( DMARDs ) , biologic response modify agent ) . Group 2 3 . Subjects currently experience active establish RA ( duration symptom ≥ 2 year ) accord 2010 ACR/EULAR criterion diagnosis RA screening . 4 . Subjects active establish RA currently receive methotrexate ( MTX ) , must receive least 12 week , stable dose ( ≥15mg/week ) least 6 week prior screen . They must biologic drug naïve . These subject must receive least 5 mg oral folic acid weekly . 5 . Subjects diagnose RA must seropositive document rheumatoid factor ( RF ) anticyclic citrullinated peptide ( anti CCP ) positivity . If documented history RF anti CCP positivity available , RF anti CCP titer obtain screen Group 3 6 . Healthy subject without RA . 7 . All subject must sit diastolic BP ≤90 mm Hg and/or sit systolic BP ≤ 140 screen 8 . Subjects must fast plasma glucose ( FPG ) ≤ 100 mg/dL . 9 . If subject establish RA receive oral corticosteroid , dose must ≤7 mg/day prednisone ( equivalent ) stable least 28 day prior screen . 10 . Subjects able willing give write informed consent comply requirement study protocol . Informed consent must obtain prior studyrelated procedure . A copy sign informed consent form must give subject 11 . Patients must BMI le 42 1 . Major surgery ( include joint surgery ) within 8 week prior screen . 2 . Rheumatic autoimmune disease RA , include systemic lupus erythematosus ( SLE ) , mixed connective tissue disease ( MCTD ) , scleroderma , polymyositis , significant systemic involvement secondary RA ( vasculitis , pulmonary fibrosis Felty 's syndrome ) . Prior history current inflammatory joint disease RA ( gout , Lyme disease , seronegative spondyloarthropathy include reactive arthritis psoriatic arthritis ) 3 . Functional class IV define ACR Classification Functional Status RA 4 . Current treatment traditional DMARDs MTX within 4 week screen visit ( For subject establish RA ) . Current prior use Leflunomide exclusionary . 5 . Treatment investigational agent within 4 week ( 5 halflives investigational agent , whichever long ) screen 6 . Exposure Biologic Response Modifying Agent RA 7 . Intraarticular parenteral corticosteroid within 6 week prior screen ( For subject establish RA ) 8 . Exclusionary laboratory : Serum creatinine &gt; 2 mg/dL , ALT AST &gt; 2.0 x ULN , total bilirubin &gt; 2.0 x ULN , platelet count &lt; 100 x 10⁹ /L , hemoglobin &lt; 8.5 g/dL , WBC count &lt; 1,000/mm³ , absolute neutrophil count &lt; 1,000/ mm³ , absolute lymphocyte count &lt; 500/mm³ , triglyceride &gt; 400 mg/dL , Serum potassium &lt; 3.5 &gt; 5.5 mEq /L without medication , serum albumin &lt; 2.5 g/dL , Gamma GT 3.0 x UNL 9 . Smokers ( use tobacco product recent past &lt; 6 month ) . Urine cotinine level measure screening subject . Smokers define subject report cigarette use urine cotinine great 200 ng/mL . 10 . Pregnant woman nurse mother 11 . Females child bear potential use reliable mean contraception 12 . Evidence serious uncontrolled concomitant cardiovascular ( include know CAD , HTN , hyperlipidemia ) , nervous system , pulmonary , renal , hepatic , endocrine GI disease . 13 . Uncontrolled disease state , asthma , psoriasis , inflammatory bowel syndrome , flare commonly treated corticosteroid . 14 . History presence severe bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat treat ) . 15 . History cardiovascular abnormality include myocardial infarction , angina pectoris , hypertensive encephalopathy , stroke , transient ischemic attack , valvular heart disease , ventricular arrhythmia AV block , atrial fibrillation cardiac revascularization/angioplasty . Symptoms clinical evidence congestive heart failure know leave ventricular ejection fraction &lt; 40 % . 16 . Medical history clinically significant ECG abnormality , include history prolong QTinterval syndrome . 17 . History autonomic dysfunction 18 . Known active current history recurrent bacterial , viral , fungal , mycobacterial , infection atypical mycobacterial disease , hepatitis B C , HIV , herpes zoster , major episode infection require hospitalization treatment IV antibiotic within 4 week screen oral antibiotic within 2 week prior screen . 19 . Any malignancy except skin cancer ( basal cell squamous cell ) diagnose within previous 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Premature endothelial dysfunction</keyword>
	<keyword>Early Rheumatoid Arthritis</keyword>
	<keyword>establish rheumatoid arthritis</keyword>
	<keyword>Premature endothelial dysfunction early rheumatoid arthritis</keyword>
	<keyword>Premature endothelial dysfunction establish rheumatoid arthritis</keyword>
	<keyword>Endothelial function healthy subject</keyword>
</DOC>